June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
The roles of autophagy and mTOR in the neuro-protection of optic nerve crush models in rats
Author Affiliations & Notes
  • Rong-Kung Tsai
    Institute of Eye Research, Tzu-Chi Medical Center, Hualien, Taiwan
    Institute of Medical Sciences, Tzu Ci University, Hualien, Taiwan
  • Yao-Tseng Wen
    Institute of Eye Research, Tzu-Chi Medical Center, Hualien, Taiwan
  • Footnotes
    Commercial Relationships   Rong-Kung Tsai, None; Yao-Tseng Wen, None
  • Footnotes
    Support  Grant of Buddhist Tzu Ci General Hospital TCRD104-22
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 3871. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Rong-Kung Tsai, Yao-Tseng Wen; The roles of autophagy and mTOR in the neuro-protection of optic nerve crush models in rats. Invest. Ophthalmol. Vis. Sci. 2017;58(8):3871.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To illustrate the role of autophagy machinery in optic nerve (ON) injury, two autophagy activators, rapamycin and p62 siRNA, were used to evaluate their neuroprotective effects in a rat model of ON crush .

Methods : Adult male Wistar rats immediately received an intravitreal injection of p62 siRNA or intravitreal injections of rapamycin after ON crush experiments. Two weeks after ON crush, the neuroprotective effects were evaluated by measuring flash visual-evoked potentials (fVEP) and RGC survival rate. The anti-apoptotic effect was measured by TUNEL assay in the retinal sections. The inflammatory condition in the ON was determined by counting the number of ED1-positive cells. The level of autophagy-related markers was examined by immunoblotting and immunostaining analysis.

Results : The P1-N2 amplitudes of fVEP were found significantly higher in the p62 siRNA-treated group compared with that of the rapamycin-treated group and the ON crush group (41.5±10.5 vs. 25.2±9.8 and 14.6±11.6, p<0.05). The RGC densities of central retina and mid-peripheral retina were statistically higher in the p62 siRNA-treated group than that of the rapamycin-treated groupand the crush group (center: 1282±148; 573±144 and 636±160 respectively, mid-periphery: 882±148, 460±96 and 462±230 respctively; p<0.05). The number of apoptotic RGC was compatible with RGC densities by reducing 2.26- and 2.34-fold of p62 siRNA treatment as comparing with the rapamycin and the scramble siRNA in ON-crush rats. Macrophage infiltration at the ONs were statistically lower in the p62 siRNA-treated group compared with the rapamycin-treated group and the ON crush group (86±40 vs. 277.0±154.6 and 301.3±115.4, p<0.05). Both immunoblotting and immunostaining indicated that intravitreal injections of p62 siRNA and rapamycin significantly elevated the expression of LC3 II and LAMP1 and reduced P62 in contrast to scramble siRNA. However, rapamycin significantly reduced 4.2-fold of retinal mTOR expression compared with treatment with p62-siRNA in the ON crush model (p<0.05).

Conclusions : Conclusions:
Intravitreal injection of p62 siRNA and rapamycin can activate autophagy after ON crush. However, intravitreal injections of rapamycin also down-regulate the m-TOR expression. This crucial mechanism explains the difference of results between p62 siRNA and rapamycin in the rat ON crush model.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×